1,915
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Injectable oxygenation therapeutics: evaluating the oxygen delivery efficacy of artificial oxygen carriers and kosmotropes in vitro

ORCID Icon, ORCID Icon & ORCID Icon
Pages 317-324 | Received 06 Jul 2020, Accepted 17 Jan 2021, Published online: 19 Mar 2021

References

  • Spiess BD. Perfluorocarbon emulsions as a promising technology: a review of tissue and vascular gas dynamics. J Appl Physiol. 2009;106(4):1444–1452.
  • Graham K, Moon-Massat PF, Unger EC. 2017 Military supplement: dodecafluoropentane emulsion (DDFPe) as a resuscitation fluid for treatment of hemorrhagic shock and traumatic brain injury: a review. Shock. 2019;52:50–54.
  • Mullah SH, Saha BK, Abutarboush R, et al. Perfluorocarbon NVX-108 increased cerebral oxygen tension after traumatic brain injury in rats. Brain Res. 2016;1634:132–139.
  • Cheung AT, To PL, Chan DM, et al. Comparison of treatment modalities for hemorrhagic shock. Artif Cells Blood Substit Immobil Biotechnol. 2007;35(2):173–190.
  • Brown AT, Arthur MC, Nix JS, et al. Dodecafluoropentane emulsion (DDFPe) decreases stroke size and improves neurological scores in a permanent occlusion rat stroke model. Open Neurol J. 2014;8:27–33.
  • Culp WC, Woods SD, Skinner RD, et al. Dodecafluoropentane emulsion decreases infarct volume in a rabbit ischemic stroke model. J Vasc Interv Radiol. 2012;23(1):116–121.
  • Kawaguchi AT. Artificial oxygen carriers: a clinical point of view. Artif Organs. 2009;33(2):97–99.
  • Remy B, Deby-Dupont G, Lamy M. Red blood cell substitutes: fluorocarbon emulsions and haemoglobin solutions. Br Med Bull. 1999;55(1):277–298.
  • Riess JG. Understanding the fundamentals of perfluorocarbons and perfluorocarbon emulsions relevant to in vivo oxygen delivery. Artif Cells Blood Substit Immobil Biotechnol. 2005;33(1):47–63.
  • Spiess BD. Basic mechanisms of gas transport and past research using perfluorocarbons. Diving Hyperb Med. 2010;40(1):23–28.
  • Riess JG, Le Blanc M. Solubility and transport phenomena in perfluorochemicals relevant to blood substitution and other biomedical applications. Pure Appl Chem. 1982;54(12):2383–2406.
  • Jayaraman MS, Graham K, Unger EC. In vitro model to compare the oxygen offloading behaviour of dodecafluoropentane emulsion (DDFPe). Artif Cells Nanomed Biotechnol. 2019;47(1):783–789.
  • Johnson JL, Dolezal MC, Kerschen A, et al. In vitro comparison of dodecafluoropentane (DDFP), perfluorodecalin (PFD), and perfluoroctylbromide (PFOB) in the facilitation of oxygen exchange. Artif Cells Blood Substit Immobil Biotechnol. 2009;37(4):156–162.
  • Johnson JLH. 2017. Oxygen carriers: are they enough for cellular support? In: Lapchak PA, Zhang JH, editors. Neuroprotective therapy for stroke and ischemic disease. Cham: Springer International Publishing. p. 621–640.
  • Casanova-Morales N, Alavi Z, Wilson CAM, et al. Identifying chaotropic and kosmotropic agents by nanorheology. J Phys Chem B. 2018;122(14):3754–3759.
  • Holland RA, Shibata H, Scheid P, et al. Kinetics of O2 uptake and release by red cells in stopped-flow apparatus: effects of unstirred layer. Respir Physiol. 1985;59(1):71–91.
  • Huxley VH, Kutchai H. The effect of the red cell membrane and a diffusion boundary layer on the rate of oxygen uptake by human erythrocytes. J Physiol. 1981;316:75–83.
  • Gainer JL, Sheehan JP, Larner JM, et al. Trans sodium crocetinate with temozolomide and radiation therapy for glioblastoma multiforme. J Neurosurg. 2017;126(2):460–466.
  • Johnson JL, Unger E. 2014. Buffered oxygen therapeutic. United States Patent 8,822,549, September 2, 2014.
  • Gainer JL. 1996. Trans-sodium crocetinate, methods of making and methods of use thereof. United States Patent 6,060,511.
  • Culp WC, Onteddu SS, Brown A, et al. Dodecafluoropentane emulsion in acute ischemic stroke: a phase Ib/II randomized and controlled dose-escalation trial. J Vasc Interv Radiol. 2019;30(8):1244–1250 e1241.
  • Kreimeier U. Pathophysiology of fluid imbalance. Crit Care. 2000;4(Suppl 2):S3–S7.
  • Pittman RN. 2011. Regulation of tissue oxygenation. In: Neil Grange D, Granger JP, editors. Integrated systems physiology: from molecule to function to disease. San Rafael (CA): Morgan & Claypool Life Sciences.
  • Gainer JL. Trans-sodium crocetinate for treating hypoxia/ischemia. Expert Opin Investig Drugs. 2008;17(6):917–924.
  • Dunn J-OC, Mythen MG, Grocott MP. Physiology of oxygen transport. BJA Education. 2016;16(10):341–348.
  • Popel AS. Theory of oxygen transport to tissue. Crit Rev Biomed Eng. 1989;17(3):257–321.
  • Sandor B, Marin M, Lapoumeroulie C, et al. Effects of Poloxamer 188 on red blood cell membrane properties in sickle cell anaemia. Br J Haematol. 2016;173(1):145–149.
  • Ballas SK, Files B, Luchtman-Jones L, et al. Safety of purified poloxamer 188 in sickle cell disease: phase I study of a non-ionic surfactant in the management of acute chest syndrome. Hemoglobin. 2004;28(2):85–102.